Serum LINC00339 is a promising biomarker for prognosis prediction of nasopharyngeal carcinoma.

This study clarified that LINC00339 was upregulated in nasopharyngeal carcinoma, and that serum LINC00339 may act as a diagnostic or prognostic marker, and a hopeful therapeutic target for patients with nasopharyngeal carcinoma.